Unknown

Dataset Information

0

DMSA-SPECT: A Novel Approach to Nephron Sparing SBRT for Renal Cell Carcinoma.


ABSTRACT:

Purpose

Stereotactic body radiation therapy (SBRT) treatment planning for renal cell carcinoma requires accurate delineation of tumor from normal tissue due to the radiosensitivity of normal renal cortical tissue. Tc-99m dimercapto succinic acid (DMSA) renal imaging is a functional imaging technique that precisely differentiates normal renal cortical tissue from tumor. There are no prior publications reporting using this imaging modality for SBRT treatment planning.

Methods and materials

A 59-year-old female with stage IV renal cell carcinoma progressed on systemic therapy and was dispositioned to primary cytoreduction with SBRT. She had baseline renal dysfunction and her tumor was 9 cm without clear delineation from normal tissue on conventional imaging. DMSA-single-photon emission computerized tomography (SPECT)/computed tomography (CT) was used for treatment planning.

Results

DMSA-SPECT/CT precisely delineated normal renal cortical tissue from tumor. Three months after treatment, labs were stable and DMSA-SPECT/CT was unchanged. The treated lesion had markedly decreased positron emission tomography avidity.

Conclusions

DMSA-SPECT or SPECT/CT can be incorporated into radiation therapy planning for renal lesions to improve target delineation and better preserve renal function.

SUBMITTER: Chevli N 

PROVIDER: S-EPMC8655433 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC5540622 | biostudies-other
| S-EPMC5408158 | biostudies-literature
| S-EPMC8725354 | biostudies-literature
| S-EPMC7801353 | biostudies-literature
| S-EPMC4251855 | biostudies-literature
| S-EPMC8418257 | biostudies-literature
| S-EPMC7406342 | biostudies-literature
2021-12-15 | PXD023296 | Pride
| S-EPMC5559895 | biostudies-other
| S-EPMC7067827 | biostudies-literature